Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BBP Virtus LifeSci Biotech Products ETF

交易中 11-03 10:04:08 EST

103.88

+1.91

+1.88%

最高103.88	最低103.88	成交量3,014
今开103.88	昨收101.97	日振幅0.00%
总市值1.35亿	流通市值1.35亿	总股本130.00万
成交额31.30万	换手率0.23%	流通股本130.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":103.8823,"timestamp":1793717967313,"preClose":101.97,"halted":0,"volume":3014,"delay":0,"changeRate":0.01875355496714722,"floatShares":1300004,"shares":1300004,"eps":0,"marketStatus":"交易中","change":1.9123,"latestTime":"11-03 10:04:08 EST","open":103.8823,"high":103.8823,"low":103.8823,"amount":312964.4166,"amplitude":0,"askPrice":104.43,"askSize":100,"bidPrice":103.13,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1793739600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":101.97,"sharesOutstanding":600004,"nav":104.222,"aum":135488485.98,"bidAskSpread":0.002345,"postHourTrading":{"tag":"盘后","latestPrice":101.97,"preClose":101.97,"latestTime":"19:30 EST","volume":8,"amount":815.76,"timestamp":1793665802904,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.210762,"impliedVol":0.2745,"impliedVolPercentile":0.9402},"requestUrl":"/m/hq/s/BBP","defaultTab":"news","newsList":[{"id":"2680763426","title":"SUPERNUS与INDIVIOR完成合并，打造多元化中枢神经系统生物制药领军企业。","url":"https://stock-news.laohu8.com/highlight/detail?id=2680763426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680763426?lang=zh_cn&edition=full","pubTime":"2026-11-02 22:19","pubTimestamp":1793629151,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","IBBQ","MRNY","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679295224","title":"诺华刚渡过一轮专利悬崖，但新一轮危机已迫在眉睫","url":"https://stock-news.laohu8.com/highlight/detail?id=2679295224","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679295224?lang=zh_cn&edition=full","pubTime":"2026-10-30 17:08","pubTimestamp":1793351280,"startTime":"0","endTime":"0","summary":"诺华刚刚走出史上冲击最猛烈的一轮专利悬崖，三季度盈利能力得到改善。11 月中旬诺华即将公布长期增长战略，这件事也凸显出该药企面临的一大挑战。和奥法木单抗不一样，雷米布鲁替尼旨在调节细胞活性，而非直接清除细胞。一项评估雷米布鲁替尼治疗进展型多发性硬化症效果的临床试验还在推进，预计 2031 年公布结果。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-10-30/doc-iniwywts5559864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0070302665.USD","IE0002141913.USD","PPH","IHE","PJP","TRUH","IE00BFTCPJ56.SGD","BBH","BK4585","APXH","FXH","IE00BJJMRZ35.SGD","BBP","LU0211331839.USD","TMED","LU0320765489.SGD","MEDI","BK4578","JDOC","IE00B2B36J28.USD","LU0208291251.USD","BME","RSPH","MEDX","IE00BJT1NW94.SGD","NVS","GSKH","IE0009355771.USD","PBPH","BK4532","BK4588","FHLC","IYH","IE00B4R5TH58.HKD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679262507","title":"赛诺菲Q3利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2679262507","media":"智通财经","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679262507?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:42","pubTimestamp":1793346170,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，凭借旗下畅销皮肤及哮喘药物Dupixent的需求增长，赛诺菲连续第二个季度上调全年销售和利润预期。Dupixent的强劲表现抵消了疫苗销售下滑的影响。此外，赛诺菲在药品销售和推广相关费用上的支出也低于预期。投资者等待重大收购，新药开始贡献增量投资者正在等待一项重大收购，标的很可能是处于后期开发阶段的资产，以便及时推向市场，抵消部分Dupixent销售损失。Roger称，赛诺菲预计将在年底前更新其战略优先事项。","market":"us","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515976.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"赛诺菲Q3利润大超预期，Dupixent需求强劲难掩专利悬崖隐忧","news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BBH","APXH","FXH","TRUH","FHLC","MEDI","SNY","BK4007","BBP","IYH","IE00BFXG1179.USD","PPH","BK4585","JDOC","RSPH","PBPH","IHE","BK4588","TMED","GSKH","PJP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678643331","title":"DeLLphi-305 Ⅲ期临床试验结果显示：英飞凡联合安泰适一线治疗广泛期小细胞肺癌，将死亡风险降低58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678643331","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678643331?lang=zh_cn&edition=full","pubTime":"2026-10-26 17:47","pubTimestamp":1793008020,"startTime":"0","endTime":"0","summary":"联合治疗组约有79%的患者在一年时仍存活，而单药组这一比例为53%。联合治疗组的中位PFS为7.4个月，而单药组为1.9个月。联合方案治疗导致的治疗终止发生率较低，且未发生与治疗相关的死亡事件。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"prnasia","url":"http://wwwold.prnasia.com/story/archive/5080617_ZH80617_1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/5080617_ZH80617_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BIB","LU0128525929.USD","LU2237443465.HKD","LU1992135399.USD","XPH","LU2237443549.SGD","PJP","SBIO","IDNA","IBB","IEHS","LFSC","BBH","AZNH","IYH","CANC","IEIH","WDNA","PBE","BIOY","LU2322448791.USD","AZN","IE00B5TLWC47.USD","MRNX","FTXH","HELX","LU1992135472.HKD","LU0289739699.SGD","LU2272731865.HKD","BBP","SYNB","PBPH","PPH","BME","RXL","LU2417539215.USD","PSCH","IBRN","LU2089984988.USD","BK4007","XBIX","MEDI","LU0708994859.HKD","LU0889565916.HKD","GNOM","MRNY","FBT","LU2237443382.USD","TMED","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677086546","title":"赛默飞世尔（TMO）Q3营收121亿美元同比增9% 生物制药板块收入69亿美元增15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677086546","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677086546?lang=zh_cn&edition=full","pubTime":"2026-10-21 22:55","pubTimestamp":1792594548,"startTime":"0","endTime":"0","summary":"金吾财讯 | 赛默飞世尔 披露2026年第三季度财报，整体业绩优于市场预期，核心驱动力来自实验室产品及生物制药服务板块的亮眼表现。公司总部位于马萨诸塞州沃尔瑟姆，三季度营收 121亿美元，同比增约9%，超出市场一致预期1.9亿美元；其中实验室产品和生物制药服务业务营收69亿美元，同比增长约15%，分析师此前预期为66亿美元。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250109/Y2I4NzEzZWQyOWU1MzI2NzgyODY2NzI0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/Y2I4NzEzZWQyOWU1MzI2NzgyODY2NzI0.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"307468","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBP","03069","MRNY","TMO","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676475688","title":"葛兰素史克(GSK.US)、Inovio(INO.US)、Agios(AGIO.US)扎堆候审，美股创新药迎FDA审批窗口","url":"https://stock-news.laohu8.com/highlight/detail?id=2676475688","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676475688?lang=zh_cn&edition=full","pubTime":"2026-10-19 19:25","pubTimestamp":1792409117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PTH","RXL","LNGR","BBP","MEDX","FBT","INO","IBBQ","AGIO","BK4568","PILL","BBC","BK4583","IBBJ","BK4139","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676639504","title":"DISC MEDICINE INC.股价飙升41%，此前该公司公布了BITOPERTIN三期临床试验结果。","url":"https://stock-news.laohu8.com/highlight/detail?id=2676639504","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676639504?lang=zh_cn&edition=full","pubTime":"2026-10-19 17:30","pubTimestamp":1792402213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2473716301.USD","IE00B5TLWC47.USD","RSPH","GNOM","WDNA","LU2322448791.USD","BBP","CANC","BIOY","BBH","AZNH","LU1992135399.USD","BIB","LU2272731600.USD","MEDI","BK4585","MRNX","XBIX","FBT","IEIH","LU2322448957.HKD","PPH","PSCH","IYH","MRNY","RXL","PBE","PJP","TMED","SBIO","HELX","SYNB","BK4588","PBPH","LU2272731865.HKD","BME","LFSC","LU2272731782.SGD","IEHS","IBB","FTXH","IBRN","IDNA","LU1992135472.HKD","XPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675992340","title":"美国生物制药公司Liquidia股价飙升41%，创2023年12月以来最大盘中涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2675992340","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675992340?lang=zh_cn&edition=full","pubTime":"2026-10-14 21:35","pubTimestamp":1791984900,"startTime":"0","endTime":"0","summary":"10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与项飙现场对话！\n名额有限，手慢无。让我们共赴可持续之约！【点击报名】每经AI快讯，10月14日，美国生物制药公司Liquidia股价飙升41%，创2023年12月以来最大盘中涨幅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-10-14/doc-inivffth4448528.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-10-14/doc-inivffth4448528.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MRNY","BBP","BK1610","03069","IBBQ","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675474783","title":"美国生物制药公司Liquidia股价飙升41%，创2023年12月以来最大盘中涨幅。","url":"https://stock-news.laohu8.com/highlight/detail?id=2675474783","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675474783?lang=zh_cn&edition=full","pubTime":"2026-10-14 21:34","pubTimestamp":1791984877,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBP","MRNX","IBBQ","MRNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674342870","title":"纳微科技与智翔金泰签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2674342870","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674342870?lang=zh_cn&edition=full","pubTime":"2026-10-12 20:32","pubTimestamp":1791808379,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNX","MRNY","IBBQ","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674865591","title":"美股异动 | 美国临床阶段生物制药公司Retension Pharmaceuticals(RTSN.US)登陆美股市场 开盘后股价跌超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674865591","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674865591?lang=zh_cn&edition=full","pubTime":"2026-10-10 00:21","pubTimestamp":1791562908,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，Retension Pharmaceuticals(RTSN.US)登陆美股市场，截至发稿，该股跌超10%，报10.77美元。IPO价格为12美元。Retension Pharmaceuticals是一家美国临床阶段生物制药公司，专注于开发治疗高血压及其他心血管疾病的创新药物。公司的核心在研药物RTN-001是一款新一代磷酸二酯酶5(PDE5)抑制剂，主要针对血压未得到有效控制及难治性高血压患者，目前正开展IIb期临床试验。该药物通过增强血管中的一氧化氮信号传导，帮助血管舒张、降低血压，其全球独家开发许可来自法国制药巨头赛诺菲安万特(SNY.US)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1505512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03069","BK1610","RTSN","BBP","MRNY","IBBQ","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673501811","title":"科创板集成电路、创新药研发成果进入实质兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2673501811","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673501811?lang=zh_cn&edition=full","pubTime":"2026-10-07 19:56","pubTimestamp":1791374163,"startTime":"0","endTime":"0","summary":"近期，科创板公司研发频传利好消息，从创新药的首例入组和新适应证获批，到集成电路的存储平台量产与核心芯片交付，越来越多成果转化为实实在在的创新产出，科创板硬科技企业正从“持续投入”走向“成果兑现”。集成电路板块多点突破，存储、端侧AI、模拟与车规芯片均有实质进展落地。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202610073888922323.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202610073888922323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GDOC","SBIO","LFSC","APXH","BBP","IBB","PBE","BIOY","BK4585","WRND","159546","BK4588","KSTR","XLVI","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672268507","title":"生物制药公司Agenus报告称，其BOT+BAL联合疗法在复发性卵巢癌患者中取得了48% 的估计三年生存率。","url":"https://stock-news.laohu8.com/highlight/detail?id=2672268507","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672268507?lang=zh_cn&edition=full","pubTime":"2026-10-03 23:04","pubTimestamp":1791039869,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BBP","03069","BK1610","MRNX","MRNY","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672753398","title":"三星生物制药与梯瓦制药扩大战略合作，推进至多六款候选生物类似药研发.","url":"https://stock-news.laohu8.com/highlight/detail?id=2672753398","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672753398?lang=zh_cn&edition=full","pubTime":"2026-10-01 16:30","pubTimestamp":1790843422,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2272731782.SGD","XPH","IBBQ","BK4588","BK4559","IBB","LU2322448791.USD","LU2473716301.USD","IE00B5TLWC47.USD","BK4596","BK4557","BK4007","LU2324357040.USD","LU1992135399.USD","MRNX","BBP","LU1992135472.HKD","LU1983299246.USD","BK4584","LU2272731865.HKD","TEVA","BK4585","LU2322448957.HKD","MRNY","EMXC","PPH","BK4566","LU2272731600.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671564271","title":"科创板收盘播报：科创综指跌1.81% 生物制药股涨幅靠前","url":"https://stock-news.laohu8.com/highlight/detail?id=2671564271","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671564271?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:34","pubTimestamp":1790753669,"startTime":"0","endTime":"0","summary":"新华财经北京9月30日电（罗浩）科创50指数和科创综指30日早间分别以0.46%和0.56%的涨幅高开。两股指早盘期间整体呈震荡下行态势，午后窄幅整理，收盘时均大幅下跌。截至收盘，科创50指数报1530.01点，跌幅2.51%，成分股总成交额约719亿元，成交额较上一交易日小幅放量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"east_money_stock","url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.eastmoney.com/news/11134,202609303887685155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["IBBQ","KSTR","MRNX","03069","MRNY","BK1610","BBP","000680.SH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671949322","title":"纳微半导体美股盘前涨近13%，获得美国陆军拨款开发下一代10kV碳化硅功率半导体；生物制药公司SMMT大涨超23%，阿斯","url":"https://stock-news.laohu8.com/highlight/detail?id=2671949322","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671949322?lang=zh_cn&edition=full","pubTime":"2026-09-29 16:03","pubTimestamp":1790669005,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SMMT","MRNY","IBBQ","STHH","LU2488822045.USD","BK4139","MRNX","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671626576","title":"生物制药公司 CSL 表示，它正在与亚马逊网络服务合作，以推进生物制药研发，利用人工智能和云计算技术支持其研究和临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2671626576","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671626576?lang=zh_cn&edition=full","pubTime":"2026-09-29 07:58","pubTimestamp":1790639916,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NEWZ","AIO","BERZ","BBP","FWD","TARK","FBT","CPNQ","AIFD","QSWN","SKYU","LCLG","LRGE","ANEW","QTOC","VUSE","CLDL","XT","IBBQ","AMZZ","ARTY","AIBU","FDIF","CLOU","NBDS","GOGL","FCLD","GOOL","PBOT","GK","DQJN","AMZN","KOMP","CHAT","MQQQ","MVPS","MRNY","AQGX","TECY","AGIX","QID","CWC","QQA","MSFC","SKYY","WPAI","OGIG","CLDS","MFIG","AIQU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669484013","title":"佳兆业健康(00876)：中文股份简称将更改为“青海生物制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669484013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669484013?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:44","pubTimestamp":1790174658,"startTime":"0","endTime":"0","summary":"更改公司名称后，于香港联交所买卖股份之英文股份简称将由“KAISA HEALTH”更改为“QH BIO PHARMA”，而中文股份简称将由“佳兆业健康”更改为“青海生物制药”，自2026年9月28日上午九时正起生效。本公司于香港联交所之股份代号保持不变，仍为“876”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1500165.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1239","03069","BBP","IBBQ","BK1222","BK1230","MRNY","BK1154","BK1121","02954","MRNX","00876"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114208","title":"安进股价盘前大涨逾4%，受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669114208?lang=zh_cn&edition=full","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["RSPH","IE00B5TLWC47.USD","PSCH","BBH","IBBQ","LU0109394709.USD","LU2272731865.HKD","IE00B4R5TH58.HKD","IEIH","BK4585","IEHS","WDNA","PJP","BBP","AZNH","GNOM","SBIO","XPH","AMGN","BME","IDNA","LU0058720904.USD","LU0320765992.SGD","IBRN","IBB","BK4599","MEDI","XBIX","LU1992135472.HKD","MRNX","RXL","FTXH","PPH","LU2272731782.SGD","MRNY","HELX","PBE","IYH","LFSC","PBPH","TBXU","TMED","CANC","LU2242646821.SGD","LU2473716301.USD","LU0122379950.USD","SYNB","BIOY","BIB","FBT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169682","title":"公告精选︱科达制造：拟投资约45亿元建设年产50万吨石墨负极材料一体化项目；百花医药：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169682","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669169682?lang=zh_cn&edition=full","pubTime":"2026-09-21 21:52","pubTimestamp":1789998737,"startTime":"0","endTime":"0","summary":"逸豪新材：拟定增募资不超过18亿元用于增资收购铭丰电子不低于78%股权","market":"fut","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6758003","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["GDOC","600721","SETM","BK0216","SBIO","GSKH","BIOY","BK4585","LFSC","WRND","XLVI","BK0251","BK0188","BK4588","BK0155","600499","IBB","PBE","BK0102","APXH","BBP","BK0070"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0035},{"period":"1month","weight":-0.0051},{"period":"3month","weight":0.0616},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.3664},{"period":"ytd","weight":0.276}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.013251},{"month":2,"riseRate":0.416667,"avgChangeRate":0.009089},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010237},{"month":4,"riseRate":0.583333,"avgChangeRate":0.00248},{"month":5,"riseRate":0.583333,"avgChangeRate":0.009273},{"month":6,"riseRate":0.916667,"avgChangeRate":0.050034},{"month":7,"riseRate":0.666667,"avgChangeRate":0.017627},{"month":8,"riseRate":0.666667,"avgChangeRate":0.026611},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.014886},{"month":10,"riseRate":0.583333,"avgChangeRate":-0.014067},{"month":11,"riseRate":0.833333,"avgChangeRate":0.058077},{"month":12,"riseRate":0.363636,"avgChangeRate":-0.005253}],"exchange":"ARCA","name":"Virtus LifeSci Biotech Products ETF","nameEN":"Virtus LifeSci Biotech Products ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Virtus LifeSci Biotech Products ETF,BBP,Virtus LifeSci Biotech Products ETF股票,Virtus LifeSci Biotech Products ETF股票老虎,Virtus LifeSci Biotech Products ETF股票老虎国际,Virtus LifeSci Biotech Products ETF行情,Virtus LifeSci Biotech Products ETF股票行情,Virtus LifeSci Biotech Products ETF股价,Virtus LifeSci Biotech Products ETF股市,Virtus LifeSci Biotech Products ETF股票价格,Virtus LifeSci Biotech Products ETF股票交易,Virtus LifeSci Biotech Products ETF股票购买,Virtus LifeSci Biotech Products ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Virtus LifeSci Biotech Products ETF(BBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Virtus LifeSci Biotech Products ETF(BBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}